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ABSTRACT
Introduction: Production of nitric oxide (NO) is one of the main responses elicited by a variety of 
immune cells such as macrophages (e.g. microglia, resident macrophages of brain), during inflammation. 
Evaluation of NO levels in the inflammatory milieu is considered important to the understanding of the 
intensity of an immune response; and has been performed using different methods including the Griess 
assay. To assay NO in culture, an appropriate number of cells are stimulated into an inflammatory phenotype. 
Common stimuli include lipopolysaccharide (LPS), IFN-γ and TNF-α. However, overt stimulation could 
cause cell cytotoxicity therefore an ideal concentration of LPS should be used. Objective: To set-up a 
model of BV-2 cell activation that allows the assay of detectable levels of NO. Optimization of BV-2 
microglia cell density and LPS concentrations after stimulation by bacterial lipopolysaccharide (LPS) 
for the Griess assay is demonstrated in this study. Methods: BV-2 microglia were cultured at different 
cell densities, and treated with LPS at three concentrations (1, 5, 10 µg/ml). NO production in culture 
supernatants were then measured at 18, 24, 48 and 72 hours. Moreover, methyl tetrazolium assay (MTT) 
was also performed to ensure that NO measurement is performed at no-cytotoxic concentrations of 
LPS. Results and Conclusions: NO production follows a temporal pattern. The density of 25000 cells/
well was the ideal seeding density for NO evaluation in BV-2 cells. BV-2 stimulation by LPS is dose 
dependent, and NO levels are increased proportional to the LPS concentration up to 1.0µg/ml, whereas 
the higher LPS concentrations are associated with decreased cell viability may be caused by the high 
toxic levels of LPS or NO. Although Griess assay has been commonly used by the scientists, however, 
optimization of its parameters on BV-2 cells will be useful for the experiments which will be performed 
on this particular cell line. The optimized pattern of Griess assay on BV-2 cells was achieved in this 
study, hence easier and more practical for the future scientists to perform Griess assay on BV-2 cells.
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INTRODUCTION
Monocytes which are one of the key players in an inflammation process are crucial in host defense in mammalian 
innate immune response.1 Recent evidence shows that they play a role in tissue homeostasis as well as in pathogen 
defense and repair of tissues.2 During development, they are released into the bloodstream, and enter tissues to take 
specialized role. They have been given specific names based on the organ they reside such as Kupffer cells (liver 
macrophages), mast cells (tissue macrophages), and microglia (brain macrophages).3 Different from peripheral 
tissues, existence of the blood brain barrier prevents the entry of other immune cells into the intact central nervous 
system (CNS) and thus well-being of the CNS is solely monitored by microglia. Microglia elicit responses to trauma 
or an infection4,5 through secretion of various inflammatory mediators such as growth factors (GM-CSF and TGF-β), 
cytokines (IL-4, IL-2, IL-10, TNF-α, IL-3 and IFN-γ) and prostaglandins (PGE2),3 and soluble factors such as nitric 
oxide (NO).6 Microglia are capable of phagocyting pathogens and presenting antigens to CD4+ cells. 
Both Gram positive and Gram negative bacteria may cause serious bacterial infection in the CNS like in meningitis.7,8 
Common bacteria which can cause bacterial meningitis resulting in microglial stimulation are Haemophilus influenzae 
type b, Neisseria meningitidis, Listeria monocytogenes, Streptococcus pneumoniae and Streptococcus agalactiae,9 
and therefore it is of interest to study microglial responses to pathogenic organisms.
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NO secretion is one of the major mechanisms of bacterial killing by macrophages, microglia cells and other immune 
cells.10 Apart from the crucial antimicrobial activity, NO has been shown to possess anti-tumor activity and tissue 
damaging effect. NO is a radical gas which is water soluble,11 and is derived from the amino acid L-arginine by 
inducible nitric oxide synthase (iNOS or NOS2).10 Beside NO production, other researchers also looked at other 
inflammatory cytokines which can be induced by LPS (10 ng/ml), such as TNF, IL-1β, expression of IL-10 receptor; 
IL-6, IL-12, and IL-10.10 
Measuring NO is rather difficult due to its short half-life and reactivity with free oxygen resulting in the generation of 
nitrite (NO2-). However, this end product (NO2-) is relatively stable and can be measured using various assays
12 such 
as, Griess assay. Different parameters can affect the Griess assay such as cell type, seeding density, stimulant type, 
stimulant concentration, and time points. Here in the present article, we narrate the variations in NO level that could 
arise upon changing the experimental parameters such as time point, seeding density and LPS concentration using 
Griess assay. On the other hand, in order to authenticate the experiment, it was required to test the cytotoxicity of the 
various experimental conditions tested here to avoid any misinterpretation of data. Hence, cell viability was measured 
by a colorimetric assay called methyl tetrazolium assay (MTT assay). 
METHODS
Cell Culture
Transformed microglia cells (BV-2 cells) which were immortalized by genetic alternations (Horvath, Nutile-
McMenemy, Alkaitis, & DeLeo, 2008), were cultured in Dulbecco’s Modified Eagle Medium- high Glucose, with 
5% Fetal Bovine Serum at 37°C with 5 % CO2 in a humidified incubator. The cells were rinsed with 1X phosphate 
buffered saline (PBS) twice and harvested with 0.25 % Trypsin-EDTA on reaching 80-90 % confluency. Cells with 
more than 95 % viability (measured by trypan blue staining) were used for all downstream experiments. The passage 
number of cells used in experiments was restricted between 19 to 24 in order to minimize any difference in NO 
production across different passage numbers and the parameters of the Griess assay (cell seeding density in 96-well 
plate, LPS concentration, and time points) were as followed: 25000 cells/well, stimulated with 1 µg/ml of LPS and 
NO was measured at 18, 24, 48 and 72 hours in order to evaluate the temporal pattern of NO production, 5000 cells/
well, 10000 cells/well and 25000 cells/well, stimulated with 1.0 µg/ml LPS and NO was measured at 24, 48 and 72 
hours in order to optimize cell seeding density, and 25000 cells/well, stimulated with 1.0, 5.0 and 10 µg/ml of LPS 
concentrations and NO was measured at 24, 48 and 72 hours in order to optimize LPS concentration, by Griess assay.
Cell Treatment
In order to optimize the seeding density of BV-2 cells to be used for Griess assay, BV-2 cells were seeded at 5000 
cells/well, 10000 cells/well and 25000 cells/well in a 96-well plate and allowed to attach overnight. Media were 
replaced with phenol red free media and the cells were allowed to acclimatize for 4 hours before treatment. The cells 
were then treated with bacterial lipopolysaccharide (LPS; E. coli serotype 026:B6; Sigma Cat. No. L2762) with the 
concentration of 1.0 µg/ml, and culture supernatant were analyzed for NO levels using Griess assay.
BV-2 cells were seeded at a density of 25000 cells/well of a 96-well plate and stimulated with 1 µg/ml of LPS 
and analyzed at different time points (18, 24, 48 and 72 hours), to perform the temporal pattern of NO production. 
Different LPS concentrations (1.0, 5.0 and 10.0 µg/ml) were tested to identify the optimal concentration of the 
stimulant, through Griess assay and MTT assay as well.
Griess Assay
Griess reagent was prepared by dissolving 1 % sulfanilamide (Sigma, Batch No. 126K0001) and 0.1 % N-1-naphthyl-
ethylenediamine hydrochloride (Sigma, Cat. No. 222488) in 3 % phosphoric acid freshly at each time point. Fifty 
microliter of culture supernatant was transferred to a fresh 96-well plate at respective time points and an equal volume 
of freshly prepared Griess reagent was added. Plates were incubated in the dark for 10 minutes and absorbance was 
read at 530 nanometers by Dynex MRX II microplate reader at 18, 24, 48 and 72 hours. Nitrite concentration was 
calculated with reference to a standard curve of freshly prepared sodium nitrite (0–100 μM).
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MTT assay
In order to choose suitable LPS dose, MTT assay was done on LPS treated and resting BV-2 cells parallel to Griess 
assay, at 48 and 72 hours as well. In order to perform viability test, cells were seeded in 96-well plates, and incubated 
overnight to be attached. Cells were treated with LPS with concentrations of 0.5, 1.0, 5.0 and 10 µg/ml. MTT reagent 
was prepared by dissolving 5 mg/ml of MTT powder in distilled water (Amresco, LOT No. 1247B021).  MTT reagent 
was added to the attaching cells at 48 and 72 hours and the cells were incubated for 3 hours at 37°C with 5 % CO2 in a 
humidified incubator. Afterwards, the culture supernatant was removed and DMSO was added to the wells and plates 
were incubated in the dark for 10 minutes and absorbance was read at 490 nanometers by Dynex MRX II microplate 
reader. Viability percentage was calculated with reference to a comparison of treated cells to untreated cells as control.
RESULTS
Temporal Pattern of NO Production
Figure 1 illustrates that unstimulated BV-2 cells produced NO with minimal levels and the levels remaining lower 
than 20µM at all time points tested. LPS stimulation induced NO production at 18 hours 48 and 72 hours. NO levels 
were increased significantly to 95.76 ± 23.44µM by 48 hours and126.93 ±9.69 µM by 72 hours. Therefore, further 
experiments were conducted at 48 and 72 hours. Viability of the cell at these time points were 85.04 ± 0.42 and 71.83 
± 0.25 respectively (Table 1).
Table 1. Determination of ideal LPS concentration by measuring cell viability through MTT assay on BV-2 
cells. LPS induction had the lowest toxic effect on the cells at the concentration of 1 µg/ml in BV-2 cells.
BV-2 cells at the cell density of 25000 cells/well were treated with different LPS doses (1.0, 5.0 and 10 µg/ml) 
and evaluated for viability at 48 and 72 hours via MTT assay. Cell viability showed the highest percentage at the 
concentration of 1 µg/ml, while the viability started to decrease to below 70 % at the LPS concentrations of 5.0 and 
10 µg/ml. Values are shown in mean ± SD from triplicate readings.
 Time 
 48 hours                     72 hours
Viability (% ± SD) 
BV-2 (25000 cells/well)                        100 ± 0.21                   100 ± 0.77
BV-2 + 1.0 µg/ml LPS                        85.04 ± 0.42                71.83 ± 0.25
BV-2 + 5.0 µg/ml LPS                        89.76 ± 0.38                64.86 ± 0.12
BV-2 + 10.0 µg/ml LPS                      75.35 ± 0.34                67.54 ± 0.41
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Figure 1.Time point analysis for production of nitric oxide (NO) by BV-2 cells: NO levels increased significantly 
at 48 and 72 hours, following LPS stimulation. BV-2 cells were seeded in 96-well plate at the density of 25000 
cells/well and allowed to adhere overnight. Cells were stimulated with 1 µg/ml of LPS and NO levels were measured 
at time points mentioned in the graph by Griess assay. *p<0.05 compared to untreated BV-2 cells at the corresponding 
time points. **p<0.01 compared to untreated BV-2 cells at the corresponding time points. Values are shown in mean 
± SD from triplicate readings.
Figure 2. Determination of suitable BV-2 cell seeding density for assay of nitric oxide (NO): BV-2 cells produce 
the highest NO at the cell density of 25000 cells/well. BV-2 cells were seeded in 96-well plate at the different cell 
densities and allowed to adhere overnight. Cells were stimulated with 1 µg/ml of LPS and NO levels were evaluated 
at time points mentioned in the graph by Griess assay. *p<0.01 compared to untreated BV-2 cells at the corresponding 
time points. Values are shown in mean ± SD from triplicate readings.
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Figure 3.Determination of ideal LPS concentration for assay of nitric oxide (NO) on BV-2 cells: LPS at the 
concentration of 1 µg/ml had the highest stimulation of NO production in BV-2 cells. BV-2 cells were seeded in 
96-well plate at the density of 25000 cells/well and allowed to adhere overnight. Cells were stimulated with different 
LPS concentrations (1.0, 5.0 and 10 µg/ml), and NO levels were evaluated at time points mentioned in the graph by 
Griess assay. *p<0.01 compared to untreated BV-2 cells at the corresponding time points. Values are shown in mean 
± SD from triplicate readings.
Optimization of BV-2 Seeding Density
We then sought to determine whether seeding density of BV-2 cells can influence this model of NO induction. For this, 
BV-2 cells were seeded at three different seeding densities of 5000 cells/well, 10000 cells/well and 25000 cells/well. 
NO levels were increased by 7 fold to 140.9 ± 3.47 µM in 25000 cells/well, and by 3fold to 77.56 ± 5.24 µM in 10000 
cells/well seeding densities by 72 hours. The cell density of 25000 cells/well was chosen for downstream experiments 
as NO was induced as early as 48 hours and increased to the highest level at 72 hours. 
Optimization of LPS Concentration
Measuring Nitric Oxide (NO) Production by LPS Treated cells in order to select the suitable 
LPS concentration 
As 25000 cells at 1µg/ml LPS induces sufficient amounts of NO at 48 and 72 hours, we next wanted to determine 
whether increasing LPS concentrations induces further NO induction. Therefore, effect of LPS doses 1, 5 and 10 µg/
ml on 25000 BV-2 cells/well were examined at 48 and 72 hours. At 72 hours, NO levels increased to 48.22 ± 2.69 
µM with 1.0 µg/ml of LPS concentration, 59.67 ± 2.33 µM with 5.0 µg/ml of LPS concentration and 56.4 ± 1.54 µM 
with 10.0 µg/ml of LPS concentrations, which showed that NO production by BV-2 cells was LPS dose dependent. 
However, increasing doses of LPS affected cell viability, particularly at 72 hours. Cell viability dropped to 64.86 ± 
0.12 for 5 µg/ml LPS and 67.54 ± 0.41 for 10 µg/ml LPS.
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DISCUSSION
Lipopolysaccharides have been used as a stimuli in in vitro experiments to stimulate microglia into an inflammatory 
phenotype (Tran, McCoy, Sporn, & Tansey, 2008). LPS is a microbial-derived stimulant as it is a component of gram 
negative bacteria cell wall. Utilising LPS rather than inflammatory stimuli such as TNF-α or IFN-γ simulates bacteria-
induced inflammation. As a response to inflammation, microglia secrete various mediators including nitric oxide (NO). 
NO is assayable with the Griess assay and can reveal the extent of an inflammatory response. However parameters 
such as cell number, time points and stimulant doses require optimization. This is because insufficient cells, stimulant, 
or time to assay may result in minimal NO produced. Conversely, stimulated doses that are too high may decrease cell 
viability. Therefore, this study describes the ideal parameters to allow NO in BV-2 microglia cultures to be assayed.  
It was shown by this study that LPS has dose-dependent effect on NO production by BV-2 cells, which followed 
the previous research (Amiraslani, Sabouni, Abbasi, Nazem, & Sabet, 2012; Keller, Gehri, & Keist, 1992; Lee et al., 
2001; Roy, Fung, Liu, & Pahan, 2006). LPS concentration optimized by Roy et al. which showed that the concentration 
of 0.75 µg/mL induced the highest NO production on BV-2 cells at 24 hours (Roy, et al., 2006), therefore, in this study, 
higher LPS concentrations were examined in order to find higher concentration which induce NO production.
It was shown in previous research that NO production was initiated after 12 hours of stimulation (Lee, et 
al., 2001). Furthermore, it was shown by a study that NO production initiated after 18 hours (Ring, Braun, Nizet, 
Stremmel, & Shenep, 2000). Results of time point analysis in the present study showed that NO values produced by 
BV-2 cells increased with time duration, particularly by 48 hours and 72 hours. Hence 48 and 72 hours were chosen 
as the suitable time points due to NO levels which were negligible at earlier time points even after LPS stimulation.
Results of cell density optimization demonstrated that NO production by BV-2 cells was cell density dependent. 
Considerable increase in NO production occurred at the cell density of 25000 cells/well in LPS treated cells, unlike 
resting BV-2 cells which did not show substantial NO production in none of cell seeding densities. However, resting 
BV-2 cells showed an insignificant NO production values between time points in resting BV-2 cells. Therefore, the 
results indicated that the best cell density for NO production by BV-2 cells is 25000 cells/well.
It has been shown by studies that cell density has a positive time-dependent effect on the color which is developed 
through the assay, as the viable cells have the mitochondrial enzyme of formazon production(Gerlier & Thomasset, 
1986). Hence, we have performed MTT assay to authenticate the cells which are being used are alive.  
Results of optimization in LPS concentration indicated that NO production by BV-2 cells is LPS dose dependent. 
However, there was a decrease in viability in the LPS concentration of 5 µg/ml and 10µg/ml, at72 hours, after 
performing MTT assays. LPS treated cells did not produce a remarkable concentration of NO at 24 hours across all 
of the LPS concentrations, and the values remained approximately equal. Therefore, the results demonstrated that NO 
production by BV-2 cells is LPS dose dependent up to 1µg/ml, while the cells remained more than 70% viable.
CONCLUSION
Production of NO by both CNS and peripheral macrophages are widely studied. The findings here demonstrate the 
importance of monitoring the experimental variables very closely. Within this study, BV-2 microglial production of 
NO varies temporally based on the seeding density and concentration of the stimulant (LPS). NO levels showed a 
linear relationship with time, seeding density and LPS concentration. However, viability of BV-2 cells decreased as 
the LPS concentration was increased. Thus, the study narrates the importance of optimization of variable parameters 
for individual cell types in similar assays.
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